Net profit of Concord Drugs declined 4.35% to Rs 0.22 crore in the quarter ended December 2025 as against Rs 0.23 crore during the previous quarter ended December 2024. Sales rose 57.13% to Rs 16.97 crore in the quarter ended December 2025 as against Rs 10.80 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales16.9710.80 57 OPM %5.5412.87 - PBDT0.600.90 -33 PBT0.300.53 -43 NP0.220.23 -4 Powered by Capital Market - Live News

Concord Drugs will hold a meeting of the Board of Directors of the Company on 14 February 2026.Powered by Capital Market - Live News

Net profit of Concord Drugs rose 375.00% to Rs 0.19 crore in the quarter ended September 2025 as against Rs 0.04 crore during the previous quarter ended September 2024. Sales declined 16.83% to Rs 10.28 crore in the quarter ended September 2025 as against Rs 12.36 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales10.2812.36 -17 OPM %10.707.12 - PBDT0.610.41 49 PBT0.270.07 286 NP0.190.04 375 Powered by Capital Market - Live News

Concord Drugs will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live News

Concord Drugs announced that the Annual General Meeting(AGM) of the company will be held on 30 September 2025.Powered by Capital Market - Live News